Connect with us

Published

on

Elon Musk‘s brain implant startup Neuralink, which was valued at close to $2 billion (roughly Rs. 16,500 crore) in a private fundraising round two years ago, is now worth around $5 billion (roughly Rs. 41,300 crore) based on privately executed stock trades described to Reuters by five sources with knowledge of the matter.

Some purchases by bullish investors boosted the valuation in recent months, ahead of Neuralink’s May 25 announcement that U.S. regulators had approved a human trial on its brain chip, the sources said.

Experts have said it could take several years for Neuralink to secure commercial use clearance. Kip Ludwig, former program director for neural engineering at the U.S. National Institutes of Health (NIH), said he “optimistically” expected Neuralink to take at least 10 more years to commercialize its brain implant. The company also faces other challenges that include federal probes into its handling of animal research.

Following the trial’s approval, however, Neuralink shares were marketed privately to investors in recent days at a $7 billion (roughly Rs. 57,900 crore) valuation, equivalent to $55 (roughly Rs. 4,500) per share, according to an email seen by Reuters. Reuters could not establish whether the seller found buyers for that price. The email cited the U.S. Food and Drug Administration’s (FDA) approval of the clinical trial as grounds for the deal being “sweeter.”

Neuralink executives and Musk did not respond to requests for comment.

Musk has expressed grand ambitions for Neuralink, saying its chip would allow healthy and disabled people alike to pop into neighbourhood facilities for speedy surgical insertions of devices to treat obesity, autism, depression and schizophrenia. He even sees them being used for web-surfing and telepathy. A Neuralink executive recently gave more modest short-term objectives, such as helping paralyzed patients communicate through computerized text without typing.

The stock transactions at a valuation of around $5 billion (roughly Rs. 41,300 crore) have been carried out by shareholders such as employees and the company’s early backers, rather than Neuralink selling new shares to investors. Such so-called secondary trades are an imperfect gauge of a company’s value; their volume is thin and they lack the wider market consensus of a fundraising round or initial public offering (IPO).

Neuralink’s valuation jump in secondary trades is in sharp contrast to other startups. About 85percent of pre-IPO companies are currently valued in secondary trades at an average discount of 47 percent to their last funding round, according to data provider Caplight.

In Neuralink’s last known fundraising in 2021, it raised $205 million (roughly Rs. 1,700 crore) at an approximately $2 billion (roughly Rs. 16,500 crore) valuation, according to data provider Pitchbook.

Many of the recent stock sales have been to relatively small investors, who typically focus more on getting a slice of a company owned by Musk than scrutinizing its valuation. The maximum amount sought for the Neuralink shares marketed for sale at a $7 billion (roughly Rs. 57,900 crore) valuation was just $500,000, according to the email seen by Reuters.

Sim Desai, chief executive of Hiive, an online platform where the shares are traded, said demand for Neuralink stock has been “tremendous.” He pegged the valuation that buyers are willing to pay at around $4.5 billion (roughly Rs. 37,200 crore).

Some biomedical experts are skeptical. Arun Sridhar, a scientist and entrepreneur who specializes in neuromodulation, called Neuralink’s valuation “bonkers” based on how early the brain implant is in its clinical development.

“A study to assess safety and tolerability is in no shape or form valid to justify a $5 billion (roughly Rs. 41,300 crore) valuation,” said Sridhar, who helped launch Galvani Bioelectronics, a developer of implants backed by GSK Plc and Alphabet Inc’s Verily Life Sciences. Galvani is not a competitor of Neuralink because its implants under development will be installed in an artery to the spleen to help treat rheumatoid arthritis, rather than the brain.

Investigations

The FDA initially rejected Neuralink’s request for a human trial last year, citing safety reasons, Reuters has reported. Even after securing approval, the company faces several challenges.

Neuralink has come under scrutiny from U.S. lawmakers after Reuters reported in May that its animal-research board may have violated conflict-of-interest regulations. Neuralink employees who sat on that board, which oversees the welfare of the animals that were being tested, also stood to benefit from the implant’s quick development. Neuralink stock that some of the employees hold has jumped around 150 percent in value in just two years, based on the secondary trades.

The law enforcement arm of the U.S. Department of Agriculture has been investigating Neuralink for potential animal-welfare violations. Neuralink staff told Reuters last year that the company was rushing and botching surgeries on monkeys, pigs and sheep, resulting in far more animal deaths than necessary, as Musk pressured staff to receive FDA approval.

The Department of Transportation is separately probing whether Neuralink illegally transported dangerous pathogens on chips removed from monkey brains without proper containment measures.

Neither Musk nor Neuralink have responded to multiple requests for comment on the probes or the Reuters reports.

© Thomson Reuters 2023
 


The Motorola Edge 40 recently made its debut in the country as the successor to the Edge 30 that was launched last year. Should you buy this phone instead of the Nothing Phone 1 or the Realme Pro+? We discuss this and more on Orbital, the Gadgets 360 podcast. Orbital is available on Spotify, Gaana, JioSaavn, Google Podcasts, Apple Podcasts, Amazon Music and wherever you get your podcasts.

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

Affiliate links may be automatically generated – see our ethics statement for details.

Continue Reading

Science

Nasa Experiment Hints Solar Wind May Help Make Lunar Water

Published

on

By

Nasa Experiment Hints Solar Wind May Help Make Lunar Water

A recent study indicates that water on the lunar surface may come from the solar wind. Water—of most importance as rocket fuel—is present in lunar surface dust, or regolith, produced by meteoroids and charged particles impacting lunar rock. The researchers discovered that several of this graph had evidence of dampness, with between 200 and 300 parts per million of water and the molecule hydroxyl. The water and hydroxyl in the lunar graph were both low in deuterium, suggesting their hydrogen came from the sun, likely delivered to the moon by solar winds.

When the hydrogen particles interact with oxygen present in lunar surface rocks, water molecules arise. The results suggest that other airless bodies in the solar system may also have water on their surfaces, therefore highlighting the possibility of finding such water on the surface of other such objects.

NASA Confirms Solar Wind May Create Water on the Moon’s Surface

As per the report, it is claimed that scientists have hypothesised—since the 1960s—that the Sun is the source of elements generating water on the Moon. The idea is that water molecules would be produced by a chemical reaction set off by a stream of charged particles—the solar wind— slamming onto the lunar surface. NASA-led researchers have confirmed this prediction in the most realistic lab simulation of this process yet.

Given much of the water on the Moon is believed to be frozen in continuously shadowed areas at the poles, the result affects NASA’s Artemis astronaut activities near the South Pole.

Solar Wind Can Create Water on the Moon, NASA Lab Test Confirms

Constantly flowing from the sun, solar wind is mostly composed of protons—nuclei of hydrogen atoms deprived of their electrons. Our planet’s magnetic shield and atmosphere help most of the solar particles to avoid reaching the surface of Earth. But the Moon has no such protection. As computer models and lab experiments have shown, when protons smash into the Moon’s surface, which is made of a dusty and rocky material called regolith, they collide with electrons and recombine to form hydrogen atoms.

Scientists have discovered proof of both hydroxyl and water molecules beneath the moon’s surface. These molecules leave a chemical imprint that interacts with light on the regolith. Generally speaking, “water” refers to either one or a mix of both molecules since hydroxyl and water cannot be differentiated right now.

NASA astronaut Yeo and colleagues examined Apollo lunar samples using a customised tool employing two samples worth of dust. Their little particle accelerator battered the dust to create a copy of solar wind spanning many days.

Continue Reading

Science

Tyrannosaurus Rex Fossils Are Being Horded by Private Buyers: Study

Published

on

By

Tyrannosaurus Rex Fossils Are Being Horded by Private Buyers: Study

A new study has found that the private trade in Tyrannosaurus rex fossils is hampering researchers’ understanding of the iconic Cretaceous predator. Thomas Carr, an associate professor of biology at Carthage College, found that there are now more scientifically valuable T. rex specimens in private or commercial ownership than in public museums and other public trusts. The private market is likely to be an underestimate, as commercial companies are discovering twice as many T. rex fossils as museums.

Private Fossil Trade Threatens T. rex Research Progress

Carr concentrated on “scientifically informative” specimens—heads, skeletons, and isolated bones—to understand exactly how the private market sets the limitations for researchers able to obtain T. rex fossils. The most valued dinosaur sold in 2024 was a Stegosaurus, which sold for $44.6 million ; Carr wants to bring attention to his work so that other researchers may investigate how the commercial market is influencing other extinct species, including the T. rex.

As per the study, it is claimed that the private trade in Tyrannosaurus rex fossils is compromising knowledge of the famous Cretaceous predator. Director of the Carthage Institute of Palaeontology in Wisconsin and associate professor of biology at Carthage College, Thomas Carr, discovered that private or commercial ownership of T. rex specimens currently numbers more than those in public museums and other public trusts. The loss of juvenile and subadult specimens is especially worrisome, as the early growth stages of T. rex are bedevilled by a poor fossil record, and the loss of them carries the heaviest scientific cost.

Study Reveals T. rex Fossils Vanishing into Private Hands

Carr published his findings, titled “Tyrannosaurus rex: An endangered species,” in the journal Palaeontologia Electronica. He targeted “scientifically informative” specimens, such as skulls, skeletons, and isolated bones, to better understand the private market’s impact on the number of T. rex fossils available to researchers. He found 61 specimens in public trusts overall and 71 specimens—including 14 juveniles—in private ownership.

Driven by the luxury fossil market spanning all types of dinosaurs, private sales of dinosaurs outside of T. rex, as he has done with the T. rex, and the most expensive auction ever for a stegosaurus for $44.6 million in 2024, Carr believes his effort will motivate other academics to investigate how the commercial market is impacting other ancient animals.

Continue Reading

Science

Rare Ancient DNA Found in the Sahara Desert Unwinds the Verdant Past

Published

on

By

Rare Ancient DNA Found in the Sahara Desert Unwinds the Verdant Past

The silence of the Sahara desert unveils the evidence of a verdant past rooted in North African lineage, published on 2 April in the Journal Nature. The study took place in the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, together with an archaeological mission in the Sahara at Sapienza University of Rome, revealed that the two mummified individuals discovered from the Takarkori rock shelter in southwest Libya dated back over 7000 years. The findings predict the genetic history of early North African populations during the African Humid Period.

Genome Analysis

The Sahara desert was once a green savannah between 14,500 and 5000 years from the present, along the water bodies that promoted human occupation with pastoralism in the Holocene epoch. The Sahara Desert has rare DNA preservation due to its present habitat, leading to limited knowledge of genetic history. However, the Sahara was not a barren land that we know today; in fact, a green and fertile land dotted with grasslands and lakes. The study suggests that the DNA retrieval unveils a previously unknown North African ancestral lineage.

Evidence from the analysis predicts that these ancient people were different from both sub-Saharan and Eurasian groups, signalling a unique North African crowd that played a crucial role in the prehistoric period. However, the DNA contains no direct evidence of blending with neighbouring areas of that time. This, in turn, highlights the genetic isolation and importance in the history of human evolution.

The Takarkori individuals are closely related to the ancestors from Taforalt Cave, Morocco, linked with the Iberomaurusian lithic industry and predating the AHP (Analytic Hierarchy Process). However, Takarkri individuals show ten times less Neanderthal hierarchy than Valentine farmers, still significantly more than present sub-Saharan genomes. Taforalt individuals have half the Neanderthal blend of non-Africans.

Findings and Implications

The study demonstrates not just reshaping the understanding of ancient North African hierarchy but also puts strong emphasis on the importance of the Green Sahara in the past. Not just that, pastoralism flourished through cultural diffusion into a divergent, isolated North African ancestral lineage that spread in North Africa at the time of the late Pleistocene epoch. Researchers continue to explore the region, and there could be more secrets unleashed from this vast green landscape, bridging the gaps in the human origins story.

Continue Reading

Trending